お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は次世代抗体医薬品市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは次世代抗体医薬品の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の次世代抗体医薬品市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは次世代抗体医薬品のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に次世代抗体医薬品市場を分類しています。本研究に含まれる主な企業は：Roche、Amgen、Pfizer、Takeda、Daiichi Sankyo、Seagen、Astellas、Immunomedics、GSK、Immunocore、ADC Therapeutics

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Antibody Drug Conjugate (ADC)
    Bispecific Antibody (BsAb)

用途別の市場セグメント：
    Cancer
    Haemophilia
    Other Non-Cancer Diseases

本レポートの詳細内容
世界の次世代抗体医薬品市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、次世代抗体医薬品タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の次世代抗体医薬品収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の次世代抗体医薬品市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、次世代抗体医薬品市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

次世代抗体医薬品のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：次世代抗体医薬品のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：次世代抗体医薬品の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章次世代抗体医薬品企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：次世代抗体医薬品の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：次世代抗体医薬品の主要企業の概要を提供し、製品の説明と仕様、次世代抗体医薬品の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Building on the huge success of monoclonal antibody therapeutics, the next generation of antibody-based products such as Antibody Drug Conjugate (ADC) and Bispecific Antibody (BsAb) is now opening up new opportunities.

The global Next Generation Antibody Therapeutics market is projected to grow from US$ 14630 million in 2024 to US$ 43680 million by 2030, at a Compound Annual Growth Rate (CAGR) of 20.0% during the forecast period.
The global next-generation antibody therapeutics market is expected to grow significantly over the next decade, driven by the increasing prevalence of cancer, autoimmune diseases, and infectious diseases, along with advancements in biotechnology. Oncology will remain the largest segment, but there will be strong growth in autoimmune diseases, infectious diseases, and neurological conditions.
In conclusion, technological advancements, regulatory support, and the increasing use of antibodies in combination therapies will continue to fuel the market's growth, making next-gen antibody therapeutics one of the most promising areas in biopharmaceutical innovation.Global key players of next generation antibody therapeutics include Roche, Seagen, Amgen, Pfizer, Takeda, etc. The top two players hold a share over 70%. North America is the largest market, has a share about 65%, followed by Europe and Asia-Pacific, with share 16% and 15%, separately. In terms of product type, Antibody Drug Conjugate (ADC) is the largest segment, occupied for a share of 60%, and in terms of application, Cancer has a share about 66 %.
Report Includes
This report presents an overview of global market for Next Generation Antibody Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Next Generation Antibody Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Next Generation Antibody Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Next Generation Antibody Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Next Generation Antibody Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Next Generation Antibody Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roche, Amgen, Pfizer, Takeda, Daiichi Sankyo, Seagen, Astellas, Immunomedics, GSK, Immunocore, etc.

Market Segmentation
By Company
    Roche
    Amgen
    Pfizer
    Takeda
    Daiichi Sankyo
    Seagen
    Astellas
    Immunomedics
    GSK
    Immunocore
    ADC Therapeutics

Segment by Type
    Antibody Drug Conjugate (ADC)
    Bispecific Antibody (BsAb)

Segment by Application
    Cancer
    Haemophilia
    Other Non-Cancer Diseases

By Region
    North America
        United States
        Canada
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Latin America
        Mexico
        Brazil
        Rest of South America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Next Generation Antibody Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Antibody Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Next Generation Antibody Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
 Table 1. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Antibody Drug Conjugate (ADC)
 Table 3. Key Players of Bispecific Antibody (BsAb)
 Table 4. Global Next Generation Antibody Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global Next Generation Antibody Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global Next Generation Antibody Therapeutics Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global Next Generation Antibody Therapeutics Market Share by Region (2019-2024)
 Table 8. Global Next Generation Antibody Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global Next Generation Antibody Therapeutics Market Share by Region (2025-2030)
 Table 10. Next Generation Antibody Therapeutics Market Trends
 Table 11. Next Generation Antibody Therapeutics Market Drivers
 Table 12. Next Generation Antibody Therapeutics Market Challenges
 Table 13. Next Generation Antibody Therapeutics Market Restraints
 Table 14. Global Next Generation Antibody Therapeutics Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global Next Generation Antibody Therapeutics Market Share by Players (2019-2024)
 Table 16. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2023)
 Table 17. Global Next Generation Antibody Therapeutics Industry Ranking 2022 VS 2023
 Table 18. Global 5 Largest Players Market Share by Next Generation Antibody Therapeutics Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of Next Generation Antibody Therapeutics, Headquarters and Area Served
 Table 20. Global Key Players of Next Generation Antibody Therapeutics, Product and Application
 Table 21. Global Key Players of Next Generation Antibody Therapeutics, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Next Generation Antibody Therapeutics Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2019-2024)
 Table 25. Global Next Generation Antibody Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global Next Generation Antibody Therapeutics Revenue Market Share by Type (2025-2030)
 Table 27. Global Next Generation Antibody Therapeutics Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2019-2024)
 Table 29. Global Next Generation Antibody Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global Next Generation Antibody Therapeutics Revenue Market Share by Application (2025-2030)
 Table 31. North America Next Generation Antibody Therapeutics Market Size by Type (2019-2024) & (US$ Million)
 Table 32. North America Next Generation Antibody Therapeutics Market Size by Type (2025-2030) & (US$ Million)
 Table 33. North America Next Generation Antibody Therapeutics Market Size by Application (2019-2024) & (US$ Million)
 Table 34. North America Next Generation Antibody Therapeutics Market Size by Application (2025-2030) & (US$ Million)
 Table 35. North America Next Generation Antibody Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 36. North America Next Generation Antibody Therapeutics Market Size by Country (2019-2024) & (US$ Million)
 Table 37. North America Next Generation Antibody Therapeutics Market Size by Country (2025-2030) & (US$ Million)
 Table 38. Europe Next Generation Antibody Therapeutics Market Size by Type (2019-2024) & (US$ Million)
 Table 39. Europe Next Generation Antibody Therapeutics Market Size by Type (2025-2030) & (US$ Million)
 Table 40. Europe Next Generation Antibody Therapeutics Market Size by Application (2019-2024) & (US$ Million)
 Table 41. Europe Next Generation Antibody Therapeutics Market Size by Application (2025-2030) & (US$ Million)
 Table 42. Europe Next Generation Antibody Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Europe Next Generation Antibody Therapeutics Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Europe Next Generation Antibody Therapeutics Market Size by Country (2025-2030) & (US$ Million)
 Table 45. China Next Generation Antibody Therapeutics Market Size by Type (2019-2024) & (US$ Million)
 Table 46. China Next Generation Antibody Therapeutics Market Size by Type (2025-2030) & (US$ Million)
 Table 47. China Next Generation Antibody Therapeutics Market Size by Application (2019-2024) & (US$ Million)
 Table 48. China Next Generation Antibody Therapeutics Market Size by Application (2025-2030) & (US$ Million)
 Table 49. Asia Next Generation Antibody Therapeutics Market Size by Type (2019-2024) & (US$ Million)
 Table 50. Asia Next Generation Antibody Therapeutics Market Size by Type (2025-2030) & (US$ Million)
 Table 51. Asia Next Generation Antibody Therapeutics Market Size by Application (2019-2024) & (US$ Million)
 Table 52. Asia Next Generation Antibody Therapeutics Market Size by Application (2025-2030) & (US$ Million)
 Table 53. Asia Next Generation Antibody Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 54. Asia Next Generation Antibody Therapeutics Market Size by Region (2019-2024) & (US$ Million)
 Table 55. Asia Next Generation Antibody Therapeutics Market Size by Region (2025-2030) & (US$ Million)
 Table 56. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Type (2019-2024) & (US$ Million)
 Table 57. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Type (2025-2030) & (US$ Million)
 Table 58. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Application (2019-2024) & (US$ Million)
 Table 59. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Application (2025-2030) & (US$ Million)
 Table 60. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 61. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Country (2019-2024) & (US$ Million)
 Table 62. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size by Country (2025-2030) & (US$ Million)
 Table 63. Roche Company Details
 Table 64. Roche Business Overview
 Table 65. Roche Next Generation Antibody Therapeutics Product
 Table 66. Roche Revenue in Next Generation Antibody Therapeutics Business (2019-2024) & (US$ Million)
 Table 67. Roche Recent Development
 Table 68. Amgen Company Details
 Table 69. Amgen Business Overview
 Table 70. Amgen Next Generation Antibody Therapeutics Product
 Table 71. Amgen Revenue in Next Generation Antibody Therapeutics Business (2019-2024) & (US$ Million)
 Table 72. Amgen Recent Development
 Table 73. Pfizer Company Details
 Table 74. Pfizer Business Overview
 Table 75. Pfizer Next Generation Antibody Therapeutics Product
 Table 76. Pfizer Revenue in Next Generation Antibody Therapeutics Business (2019-2024) & (US$ Million)
 Table 77. Pfizer Recent Development
 Table 78. Takeda Company Details
 Table 79. Takeda Business Overview
 Table 80. Takeda Next Generation Antibody Therapeutics Product
 Table 81. Takeda Revenue in Next Generation Antibody Therapeutics Business (2019-2024) & (US$ Million)
 Table 82. Takeda Recent Development
 Table 83. Daiichi Sankyo Company Details
 Table 84. Daiichi Sankyo Business Overview
 Table 85. Daiichi Sankyo Next Generation Antibody Therapeutics Product
 Table 86. Daiichi Sankyo Revenue in Next Generation Antibody Therapeutics Business (2019-2024) & (US$ Million)
 Table 87. Daiichi Sankyo Recent Development
 Table 88. Seagen Company Details
 Table 89. Seagen Business Overview
 Table 90. Seagen Next Generation Antibody Therapeutics Product
 Table 91. Seagen Revenue in Next Generation Antibody Therapeutics Business (2019-2024) & (US$ Million)
 Table 92. Seagen Recent Development
 Table 93. Astellas Company Details
 Table 94. Astellas Business Overview
 Table 95. Astellas Next Generation Antibody Therapeutics Product
 Table 96. Astellas Revenue in Next Generation Antibody Therapeutics Business (2019-2024) & (US$ Million)
 Table 97. Astellas Recent Development
 Table 98. Immunomedics Company Details
 Table 99. Immunomedics Business Overview
 Table 100. Immunomedics Next Generation Antibody Therapeutics Product
 Table 101. Immunomedics Revenue in Next Generation Antibody Therapeutics Business (2019-2024) & (US$ Million)
 Table 102. Immunomedics Recent Development
 Table 103. GSK Company Details
 Table 104. GSK Business Overview
 Table 105. GSK Next Generation Antibody Therapeutics Product
 Table 106. GSK Revenue in Next Generation Antibody Therapeutics Business (2019-2024) & (US$ Million)
 Table 107. GSK Recent Development
 Table 108. Immunocore Company Details
 Table 109. Immunocore Business Overview
 Table 110. Immunocore Next Generation Antibody Therapeutics Product
 Table 111. Immunocore Revenue in Next Generation Antibody Therapeutics Business (2019-2024) & (US$ Million)
 Table 112. Immunocore Recent Development
 Table 113. ADC Therapeutics Company Details
 Table 114. ADC Therapeutics Business Overview
 Table 115. ADC Therapeutics Next Generation Antibody Therapeutics Product
 Table 116. ADC Therapeutics Revenue in Next Generation Antibody Therapeutics Business (2019-2024) & (US$ Million)
 Table 117. ADC Therapeutics Recent Development
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 2. Global Next Generation Antibody Therapeutics Market Share by Type: 2023 VS 2030
 Figure 3. Antibody Drug Conjugate (ADC) Features
 Figure 4. Bispecific Antibody (BsAb) Features
 Figure 5. Global Next Generation Antibody Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 6. Global Next Generation Antibody Therapeutics Market Share by Application: 2023 VS 2030
 Figure 7. Cancer Case Studies
 Figure 8. Haemophilia Case Studies
 Figure 9. Other Non-Cancer Diseases Case Studies
 Figure 10. Next Generation Antibody Therapeutics Report Years Considered
 Figure 11. Global Next Generation Antibody Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 12. Global Next Generation Antibody Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Next Generation Antibody Therapeutics Market Share by Region: 2023 VS 2030
 Figure 14. Global Next Generation Antibody Therapeutics Market Share by Players in 2023
 Figure 15. Global Top Next Generation Antibody Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Next Generation Antibody Therapeutics as of 2023)
 Figure 16. The Top 10 and 5 Players Market Share by Next Generation Antibody Therapeutics Revenue in 2023
 Figure 17. North America Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 18. North America Next Generation Antibody Therapeutics Market Share by Type (2019-2030)
 Figure 19. North America Next Generation Antibody Therapeutics Market Share by Application (2019-2030)
 Figure 20. North America Next Generation Antibody Therapeutics Market Share by Country (2019-2030)
 Figure 21. United States Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Canada Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Europe Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Next Generation Antibody Therapeutics Market Share by Type (2019-2030)
 Figure 25. Europe Next Generation Antibody Therapeutics Market Share by Application (2019-2030)
 Figure 26. Europe Next Generation Antibody Therapeutics Market Share by Country (2019-2030)
 Figure 27. Germany Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. France Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. U.K. Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Italy Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Russia Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Nordic Countries Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. China Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. China Next Generation Antibody Therapeutics Market Share by Type (2019-2030)
 Figure 35. China Next Generation Antibody Therapeutics Market Share by Application (2019-2030)
 Figure 36. Asia Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Asia Next Generation Antibody Therapeutics Market Share by Type (2019-2030)
 Figure 38. Asia Next Generation Antibody Therapeutics Market Share by Application (2019-2030)
 Figure 39. Asia Next Generation Antibody Therapeutics Market Share by Region (2019-2030)
 Figure 40. Japan Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. South Korea Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. China Taiwan Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. India Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Australia Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Share by Type (2019-2030)
 Figure 48. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Share by Application (2019-2030)
 Figure 49. Middle East, Africa, and Latin America Next Generation Antibody Therapeutics Market Share by Country (2019-2030)
 Figure 50. Brazil Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 51. Mexico Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 52. Turkey Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 53. Saudi Arabia Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 54. Israel Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 55. GCC Countries Next Generation Antibody Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 56. Roche Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2019-2024)
 Figure 57. Amgen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2019-2024)
 Figure 58. Pfizer Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2019-2024)
 Figure 59. Takeda Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2019-2024)
 Figure 60. Daiichi Sankyo Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2019-2024)
 Figure 61. Seagen Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2019-2024)
 Figure 62. Astellas Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2019-2024)
 Figure 63. Immunomedics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2019-2024)
 Figure 64. GSK Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2019-2024)
 Figure 65. Immunocore Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2019-2024)
 Figure 66. ADC Therapeutics Revenue Growth Rate in Next Generation Antibody Therapeutics Business (2019-2024)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed